Media Coverage
Media Coverage
| Date | Media Coverage | Topic |
|---|---|---|
| Aug 31, 2011 |
''As Production Goes Global, Drug Supply Faces Greater Risks to Safety, Quality'' "The adulteration, estimated to have netted the individuals responsible for adding the chemical between $1 million and $3 million, led to hundreds of adverse events, including at least 3 deaths, according to a recent report from the Pew Health Group." Source: The Journal of the American Medical Association |
Drug Safety |
| Aug 19, 2011 |
''Fletcher to Use Pew Grant to Study Olfactory Function'' "Max Fletcher, Ph.D., one of this year’s Pew Scholars in the Biomedical Sciences said that, as a scientist, he enjoys trying to answer things for which no one has answers yet. Fletcher, an assistant professor in the University of Tennessee Health Science Center’s department of anatomy and neurobiology, is one of only 22 young scientists awarded by the Pew Charitable Trusts this year. The prestigious prize includes a $240,000 grant over four years, and it has been awarded to many who went on to win such awards as the Nobel Prize." Source: The Memphis Daily News |
Biomedical Research |
| Aug 18, 2011 |
Allan Coukell, director of Medical Programs at Pew Health Group, appears on the Kojo Nnamdi Show as they explore the globalization of the drug industry and what it means for the quality and safety of our prescription drugs. Source: The Kojo Nnamdi Show |
Drug Manufacturing and Distribution, Drug Safety |
| Aug 16, 2011 |
''Nanoscale Encryption: The Solution to Counterfeit Drugs?'' "Counterfeit and stolen drugs endanger patients, undermine public health and cost billions. Are encrypted pills the answer?" Source: Popular Mechanics |
Drug Manufacturing and Distribution, Drug Safety |
| Aug 5, 2011 |
''Salmonella Strain In Turkey Recall Resists Antibiotics'' Gail Hansen, senior officer at Pew Health Group, is interviewed in an NPR segment about the debate on the practice of dosing farm animals with antibiotics. Source: National Public Radio |
Antibiotics in Food Animal Production |
| Jul 29, 2011 |
''New drug regulator asks Congress for more power'' "Drug companies should take more responsibility for the safety of ingredients sourced overseas, and Congress should make them if they do not, according to the new U.S. drug regulator for import safety." Source: Reuters |
Drug Manufacturing and Distribution, Drug Safety |
| Jul 28, 2011 |
''Tight Times Boost Business Credit Cards'' ''More small companies—already struggling with weak sales and tight lending—are being forced to rely on business credit cards to provide working capital.'' Source: The Wall Street Journal |
|
| Jul 22, 2011 |
''Consumers Hold High Hopes for New Bureau'' ''If you've ever thought someone was playing fast and lose with the rules on your credit cards, credit score or mortgage, but you had no idea where to go with your complaint, you now have a place to turn.'' Source: The Chicago Tribune |
|
| Jul 21, 2011 |
''PEW Recommends Steps to Secure the Supply Chain'' "The pharmaceutical industry and US regulatory bodies have not responded adequately to the increasing level of outsourced manufacturing in countries such as China and India, according to a new white paper by the PEW Health Group." Source: Pharmaceutical Technology |
Drug Manufacturing and Distribution, Drug Safety |
| Jul 18, 2011 |
''Pharmaceuticals: Report recommends measures to mitigate risk in a global supply chain'' "Keeping the public safe in an age of global pharmaceutical sourcing requires improved safety testing standards, greater industry oversight of contract manufacturers and suppliers, and expanded enforcement authority for FDA backed by stronger penalties and clearer accountability, says a new report from the Pew Charitable Trusts." Source: Chemical & Engineering News |
Drug Safety |
| Jul 16, 2011 |
''How Safe Are the Drugs in Your Medicine Cabinet?'' "Do you want your new prescription drugs to be made under last century's oversight? Like it or not, that's likely what you're getting -- or worse -- according to recent research from the Pew Health Group. Increasingly, Americans' medicines are made overseas in place where the oversight isn't up to U.S. standards, according to the white paper, After Heparin: Protecting Consumers from the Risks of Substandard and Counterfeit Drugs." Source: Daily Finance |
Drug Manufacturing and Distribution, Drug Safety |
| Jul 14, 2011 |
''White paper lays out reform strategy for US medicines supply chain'' "US think tank Pew Health Group has called for a wide-ranging overhaul of the US pharmaceutical distribution system, including the introduction of a federal serialisation system, in order to protect consumers from unsafe medicines." Source: Securing Pharma |
Drug Manufacturing and Distribution, Drug Safety |
| Jul 13, 2011 |
''Pew track-trace call highlights congressional dallying'' "The FDA should have the power to mandate recalls, subpoena witnesses and documents, and destroy at the border any products that pose a public safety risk. So says Pew Health Group in a just published report, After Heparin: Protecting Consumers from the Risks of Substandard and Counterfeit Drugs." Source: FiercePharma Manufacturing |
Drug Manufacturing and Distribution, Drug Safety |
| Jul 13, 2011 |
''Report Identifies Serious Gaps in Drug Safety Oversight'' "Americans' medicines are increasingly manufactured in developing countries, where oversight is lower than in the United States, according to a new white paper by the Pew Health Group." Source: Drug Discovery & Development Magazine |
Drug Manufacturing and Distribution, Drug Safety |
| Jul 13, 2011 |
''FDA calls for more congressional oversight on global drug economy'' "The Food and Drug Administration called on Congress Tuesday to make the laws that govern the global prescription drug economy stronger. In a report released Tuesday by the Pew Health Group, researchers looked at the globalization of pharmaceutical production and the domestic distribution of prescription drug, with an eye on how the FDA can more effectively regulate both." Source: The Daily Caller |
Drug Manufacturing and Distribution, Drug Safety |
